Delivery Order SPE2DB20D1109-SPE2DB23FP64A
Award Date 7/31/23
Potential Completion Date 8/1/23
Potential Value $6.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,614.73 firm-fixed-price delivery order is for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens. The contract has an ultimate completion date of June 6, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ozempic (semaglutide) 0.25-0.5 mg/dose pens. The award, valued at $106,952.68, is a firm-fixed-price delivery order with an ultimate completion date of October 8, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens. The $27,641.76 firm fixed-price delivery order has an ultimate completion date of September 24, 2024. This award is not associated with a set-aside program. As a large pharmaceutical supplier, Amerisourcebergen has been awarded numerous Indefinite Delivery Contracts...
- This federal contract award is for the delivery of Ozempic® (semaglutide) 0.25-0.5 mg/dose pens to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The $32,717.28 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on December 5, 2024, with a completion date of December 6, 2024. This contract award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
- This federal contract award is a $39,448.54 firm-fixed price delivery order for Ozempic 0.25-0.5 mg/dose pens, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The award has an ultimate completion date of May 20, 2025 and is not designated as a set-aside contract, indicating open competition. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $3,918.60 firm fixed-price contract is for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens with a period of performance through July 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,631.39 firm fixed-price delivery order is for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens. The contract has an ultimate completion date of October 10, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,157.95 firm fixed-price delivery order is for the supply of the medication Ozempic (semaglutide) in a dosage of 0.25-0.5 mg/dose, packaged in 3 mL pens. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,560.07 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL formulations. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion deadline of December 31, 2025. The award was issued on December 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $62,984.74 firm-fixed-price delivery order is for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens. The contract has a period of performance through May 15, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...